PER percheron therapeutics limited

Ann: Webinar Presentation - Phase IIb study of avicursen, page-26

  1. 3,526 Posts.
    lightbulb Created with Sketch. 677
    Agree w u sam, mri may have saved the trial to some extent. But I also believe voit and mgmnt; too costly and time consuming to set up... (Not in hindsight tho) I actually question the integrity of the ph2a mri; I asked to see the photos dec 2020 but was just circled back to the public anns.

    like sarepta, we could show cd49d and mri positivity yet fail the tangible success of the pul. Pul no doubt would still be an end point, and like all of us I believe mgmnt correlated the cd49d success to mri success to...... pul success... except thats where the line was drawn too far.

    good analysis. Sell it to sarepta for $100m get our $ back, if u havent sold. That'd be salty ay.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $71.80K 7.180M

Buyers (Bids)

No. Vol. Price($)
1 4649246 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2600000 2
View Market Depth
Last trade - 15.21pm 13/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.